PRRS

• 10 minutes

Boehringer Ingelheim Animal Health funds three research projects for improved control of swine disease PRRS with a total of 75,000 euros

Instructions how to submit research proposals are available on www.prrs.com

• 10 minutes

Boehringer Ingelheim Animal Health has sponsored European PRRS Research Award for the third time

The main aim of the award is to encourage research in the field of PRRS (Porcine Reproductive and Respiratory Syndrome)

Three project proposals receive funding of €25,000 each

• 5 minutes

Ingelheim, Germany, 26 September 2016 - Veterinarians and farmers across the globe have reached the landmark of protecting one billion sows and pigs against the potentially devastating effects of Porcine Reproductive and Respiratory Syndrome (PRRS) using Ingelvac PRRS MLV ®. The vaccine, which was launched in 1994 in the USA, is currently marketed in 19 countries in Asia, Europe, and North America. It contributes to securing the pigs’ health as well as providing healthy pork for consumers around the world.

• 10 minutes

Ingelheim, Germany, 15 March 2016 –

For the third time, Boehringer Ingelheim Animal Health sponsors the European PRRS Research Award to support applied research for improved control of the swine disease PRRS (Porcine Reproductive and Respiratory Syndrome). Research proposals for the 2016 European PRRS Research Award can be submitted until July 1st, 2016. Boehringer Ingelheim Animal Health will provide three grants of 25,000 euros each to fund research proposals that will generate new and relevant data to better understand this devastating and costly disease.